

CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 TABLETS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: 0.25–1.25 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED (POTENT)
MANUFACTURER: AXIOLABS
Letroplex 2.5 by Axiolabs provides 2.5 mg of pharmaceutical-grade Letrozole per tablet — one of the most powerful non-suicidal aromatase inhibitors available. It's ideal for controlling estrogen during anabolic steroid cycles and reversing early signs of gynecomastia.
Letrozole is a third-generation AI originally used for treating hormone-sensitive breast cancer. In bodybuilding, it effectively blocks estrogen conversion (aromatization), reducing risks of water retention, gynecomastia, and fat accumulation associated with high estrogen levels.
Start with 0.25–0.5 mg every other day to avoid crashing estrogen. Only escalate to 1.25–2.5 mg for emergency gyno reversal or high-aromatizing cycles. Due to its strength, overuse can lead to low libido, joint pain, or mood changes. Always monitor with bloodwork.
Use Letroplex during cycles involving aromatizing compounds such as:
It can also be added during PCT if estrogen rebound is a concern.
Letroplex is frequently stacked with:
We supply authentic Letroplex 2.5 mg by Axiolabs with fast and discreet U.S. delivery. Explore the Axiolabs steroid catalog for complete cycle and PCT management tools.
Scientific background: PubMed: Letrozole pharmacodynamics and estrogen suppression.
Yes, in early stages, Letroplex (Letrozole) can reduce or reverse gyno by dramatically lowering circulating estrogen levels.
Letroplex (Letrozole) is more potent than Arimidex and can eliminate nearly all estrogen. However, it has a higher risk of crashing estrogen if misused.
Due to its long half-life and strength, it's typically used every other day at low doses unless treating gyno, where higher daily doses may be used short-term.
Please log in to write LETROPLEX 2.5 MG review.
CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: CLOMIPHENE CITRATE
FORM: 50 TABLETS x 50 MG
ACTIVE HALF-LIFE: 5-7 DAYS
DOSAGE: MEN 25–100 MG/DAY
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 50 TABLETS x 1 MG
ACTIVE HALF-LIFE: ~48 HOURS
DOSAGE: 0.5–1 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 50 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: 12.5–25 MG/DAY OR EOD
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): REDUCED RISK
HEPATOTOXICITY: NO
AROMATIZATION: PERMANENTLY BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 50 TABLETS x 20 MG
ACTIVE HALF-LIFE: ~5–7 DAYS
DOSAGE: MEN 10–40 MG/DAY
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: BLOCKED AT RECEPTOR LEVEL
MANUFACTURER: AXIOLABS